Futura Medical plc announced the appointment of Ken James, the former head of consumer healthcare R&D at GlaxoSmithKline plc (GSK), as a Non-Executive Director, with effect from 31 March 2016. Mr. James has more than 40 years' experience of healthcare R&D, having joined one of GSK's predecessor businesses, Beecham Products, in 1973. Mr. James recently retired from GSK.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
37.48 GBX | +0.20% | -2.41% | +46.96% |
10/04 | Futura Medical hails results as erectile dysfunction drug drives sales | AN |
10/04 | Transcript : Futura Medical plc, 2023 Earnings Call, Apr 10, 2024 |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+46.96% | 14Cr | |
+8.92% | 11TCr | |
+10.48% | 10TCr | |
-1.83% | 2.17TCr | |
-6.45% | 2.38TCr | |
-10.39% | 1.81TCr | |
-42.36% | 1.63TCr | |
-14.45% | 1.61TCr | |
+3.76% | 1.38TCr | |
+28.94% | 1.18TCr |
- Stock Market
- Equities
- FUM Stock
- News Futura Medical plc
- Futura Medical plc Appoints Ken James as Non-Executive Director, Effective from 31 March 2016